New Zealand markets open in 6 hours 33 minutes
  • NZX 50

    11,214.49
    -220.33 (-1.93%)
     
  • NZD/USD

    0.5668
    +0.0029 (+0.52%)
     
  • ALL ORDS

    6,696.50
    +29.00 (+0.43%)
     
  • OIL

    78.91
    +2.20 (+2.87%)
     
  • GOLD

    1,642.10
    +8.70 (+0.53%)
     

Cell Lysis Market worth $4.1 billion by 2026 - Exclusive Report by MarketsandMarkets™

·4-min read
MarketsandMarkets Research Pvt. Ltd.
MarketsandMarkets Research Pvt. Ltd.

Chicago, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cell Lysis Market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2%, according to a report by MarketsandMarkets™. The growth in this market is attributed to the increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicine. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the market during the forecast period.

Browse in-depth TOC on "Cell Lysis Market / Cell Fractionation Market"
150 - Tables
40 - Figures
172 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321

By product, the cell lysis market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the larger share of the cell fractionation market. The large share of this segment can be attributed to mainly due to their repeated purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research.

Based on the cell type, the cell lysis market is segmented into mammalian, microbial, and other cells. In 2020, the mammalian cell segment accounted for the largest share of the cell fractionation market. The large share of this segment can be attributed to mammalian, microbial, and other cells.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321

Based on application, the cell lysis market is segmented into protein purification & isolation, nucleic acid isolation & purification, and other applications. The hospital segment accounted for the largest market share in 2020. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major driving factors for this market.

By end user, the cell fractionation market is segmented into research laboratories & institutes, biopharmaceutical & biotechnology companies, and other end users. The research laboratories & institutes segment accounted for the largest market share in 2020. The rising government funding for cell-based research are the major driving factors for this market

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=260138321

Geographical Growth Scenario:

The cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the market, followed by Europe. The large share of North America can be attributed to factors such as the growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries.

Key Players Cell Lysis Market are:

  • Thermo Fisher Scientific (US),

  • Merck KGaA (Germany),

  • Becton, Dickinson and Company (US),

  • Danaher Corporation (US),

  • Bio-Rad Laboratories (US),

  • Cell Signaling Technology Inc. (US),

  • Miltenyi Biotec (Germany),

  • Roche Diagnostics (Switzerland), and

  • QIAGEN N.V. (Netherlands).

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Cell Isolation Market / Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025

Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026


CONTACT: About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com